Genomic Alterations and MYD88 MUT Variant Mapping in Patients with Diffuse Large B-Cell Lymphoma and Response to Ibrutinib

ConclusionsThis study adds clinical observations withMYD88MUT patients, further helping to understand the genetic features and possible correlation ofMYD88MUT with response to ibrutinib.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research